Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ketamine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 314Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmaTher Updates on FDA NDA for Ketamine
    PharmaTher Updates on FDA NDA for Ketamine

    26 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/26/2987445/0/en/PharmaTher-Announces-Update-on-FDA-New-Drug-Application-for-Ketamine.html

    GLOBENEWSWIRE
    26 Nov 2024
    Share Share
    PharmaTher Updates on FDA NDA for Ketamine
    PharmaTher Updates on FDA NDA for Ketamine

    19 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/19/2983534/0/en/PharmaTher-Announces-Update-on-FDA-New-Drug-Application-for-Ketamine.html

    GLOBENEWSWIRE
    19 Nov 2024
    Share Share
    NRX-100 (Ketamine) Reaches Stability Milestone
    NRX-100 (Ketamine) Reaches Stability Milestone

    30 Sep 2024

    // CONTRACT PHARMA

    https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-announces-completion-of-twelve-months-of-stability-on-the-first-manufactured-commercial-scale-lot-of-nrx-100-ketamine-302262032.html

    CONTRACT PHARMA
    30 Sep 2024
    Share Share
    Ketabon To Present At-Home Ketamine Therapy At ECNP 2024
    Ketabon To Present At-Home Ketamine Therapy At ECNP 2024

    18 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/18/2948187/0/en/Ketabon-To-Present-Advancements-In-At-Home-Ketamine-Therapy-For-Treatment-Resistant-Depression-At-ECNP-Congress-2024.html

    GLOBENEWSWIRE
    18 Sep 2024
    Share Share
    PharmaTher Announces Update on FDA NDA for Ketamine
    PharmaTher Announces Update on FDA NDA for Ketamine

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940433/0/en/PharmaTher-Announces-Update-on-FDA-New-Drug-Application-for-Ketamine.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    SciSparc-Clearmind Ketamine-Based Combination Patent Application Published
    SciSparc-Clearmind Ketamine-Based Combination Patent Application Published

    29 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/29/2938125/0/en/SciSparc-Clearmind-Medicine-Collaboration-Leads-to-Publication-of-Application-for-Innovative-Ketamine-Based-Combination.html

    GLOBENEWSWIRE
    29 Aug 2024
    Share Share